GLORIA LI, FNP
Nursing at York Ave, New York, NY
License number
New York 337826
Category
Nursing
Type
Family
Address
Address
1275 York Ave, New York, NY 10065
Phone
(212) 639-2000
Personal information
See more information about GLORIA LI at radaris.comName
Address
Phone
56 Bellhaven Pl, Staten Island, NY 10314
345 E 69Th St APT 14H, New York, NY 10021
345 E 64Th St APT 10D, New York, NY 10065
235 W 22Nd St, New York, NY 10011
20 Confucius Plz APT 18F, New York, NY 10002
Professional information
Associate At Blackrock
Position:
Associate at BlackRock
Location:
Greater New York City Area
Industry:
Financial Services
Work:
BlackRock
- New York, New York since May 2008
-
Associate
Northrop Grumman Corporation
- Viginia Feb 2005 - May 2008
-
Senior Billing Analyst
Northrop Grumman Corporation
May 2004 - Feb 2005
-
Accounting Coordinator
Education:
New York Institutional of Technology 2005 - 2007
Bachelor of Science, Accounting New York Institutional of Technology 2001 - 2004
Bachelor of Applied Science, Management Information System with Minor in Business Administration
Bachelor of Science, Accounting New York Institutional of Technology 2001 - 2004
Bachelor of Applied Science, Management Information System with Minor in Business Administration
Laffey Fine Homes, Licensed Sales Associate
Position:
Licensed Sales Associate at Laffey Fine Homes
Location:
Greater New York City Area
Industry:
Real Estate
Work:
Laffey Fine Homes
- 20 Miller Place, Syosset NY 11791 -
Licensed Sales Associate
ACH Ingredients
- Syosset, NY 2009 - 2012
-
Owner
U.S. Army Reserve
1999 - 2005
-
Specialist
Education:
St John's University Queens Campus 2001
Candidate for MBA, MBA E. China Normal Univ. 1995
Bachelor of Science (B.S.), Economics
Candidate for MBA, MBA E. China Normal Univ. 1995
Bachelor of Science (B.S.), Economics
Interests:
Singing, Ballroom Dancing & International Dancing, Traveling
Languages:
English/Chinese
Project Manager At Wachtell, Lipton, Rosen &Amp; Katz
Position:
Project Manager, Automated Legal Support at Wachtell,Lipton, Rosen & Katz
Location:
Greater New York City Area
Industry:
Legal Services
Work:
Wachtell,Lipton, Rosen & Katz
since Feb 2008
-
Project Manager, Automated Legal Support
Cadwalader, Wickersham & Taft LLP
Sep 2006 - Feb 2008
-
Senior Project Manager, Practice Support
Patterson Belknap Webb & Tyler LLP
Mar 2003 - Sep 2006
-
Programmer Analyst, Litigation Support
Deutsche Bank
Oct 2001 - Mar 2003
-
Software Developer, Equity Research
Education:
Wayne State University 1996 - 1998
MS, Computer Engineering
MS, Computer Engineering
Project Manager At Cadwalader
Position:
Project manager at Cadwalader
Location:
Greater New York City Area
Industry:
Legal Services
Work:
Cadwalader
-
Project manager
Ku70ÂRelated Methods
US Patent:
6399298, Jun 4, 2002
Filed:
Jun 30, 1999
Appl. No.:
09/343634
Inventors:
Gloria C. Li - New York NY
Carlos Cordon-Cardo - New York NY
Honghai Ouyang - New York NY
Carlos Cordon-Cardo - New York NY
Honghai Ouyang - New York NY
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
International Classification:
C12Q 168
US Classification:
435 6, 435 71, 435 912
Abstract:
This invention provides a method of diagnosing a predisposition to cancer in a subject comprising: (a) obtaining a nucleic acid sample from the subject; and; (b) determining whether one or more of the subjects Ku70 alleles or regulatory regions to those alleles are deleted or different from the wild type so as to reduce or eliminate the subjects expression of polypeptide having tumor suppressor activity. This invention also provides a method of assessing the severity of cancer in a subject comprising: (a) obtaining a nucleic acid sample from the subject; and (b) determining whether one or more of the subjects Ku70 alleles or regulatory regions to those alleles are deleted or different from the wild type so as to reduce or eliminate the subjects expression of polypeptide having tumor suppressor activity. This invention also provides a method of assessing the severity of cancer in a subject comprising: determining the subcellular localization of Ku70 in the subject, wherein an abnormal subcellular localization of Ku70 indicates a predisposition to cancer.
Uses Of Ku70
US Patent:
6808887, Oct 26, 2004
Filed:
Jun 3, 2002
Appl. No.:
10/161025
Inventors:
Gloria C. Li - New York NY
Carlos Cordon-Cardo - New York NY
Honghai Ouyang - West Windsor NJ
Carlos Cordon-Cardo - New York NY
Honghai Ouyang - West Windsor NJ
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
International Classification:
C12Q 168
US Classification:
435 6, 435 4, 435 71, 435183, 435455, 436 94
Abstract:
This invention provides a method of diagnosing a predisposition to cancer in a subject comprising: (a) obtaining a nucleic acid sample from the subject; and; (b) determining whether one or more of the subjects Ku70 alleles or regulatory regions to those alleles are deleted or different from the wild type so as to reduce or eliminate the subjects expression of polypeptide having tumor suppressor activity. This invention also provides a method of assessing the severity of cancer in a subject comprising: (a) obtaining a nucleic acid sample from the subject; and (b) determining whether one or more of the subjects Ku70 alleles or regulatory regions to those alleles are deleted or different from the wild type so as to reduce or eliminate the subjects expression of polypeptide having tumor suppressor activity. This invention also provides a method of assessing the severity of cancer in a subject comprising: determining the subcellular localization of Ku70 in the subject, wherein an abnormal subcellular localization of Ku70 indicates a predisposition to cancer.
Uses Of Dna-Pk
US Patent:
7592319, Sep 22, 2009
Filed:
Nov 12, 2003
Appl. No.:
10/712642
Inventors:
Gloria C. Li - New York NY, US
Paul W. J. J. Burgman - New York NY, US
Paul W. J. J. Burgman - New York NY, US
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
International Classification:
A01N 43/04, A01N 61/00, C12Q 1/68, C12N 15/63, C07H 21/04
US Classification:
514 44, 435 6, 435 911, 4353201, 435455, 514 1, 514 2, 536 231, 536 245
Abstract:
This invention provides a method for increasing the susceptibility of a cell to DNA-damaging agents, comprising introducing into the cell an antisense oligonucleotide that specifically hybridizes to a nucleic acid encoding a DNA dependent protein kinase subunit so as to prevent expression of the DNA dependent protein kinase subunit; wherein the antisense oligonucleotide is in an amount sufficient to increase the sensitivity of the cell to heat, chemical, or radiation-induced DNA damage; and wherein the DNA dependent protein kinase subunit is a DNA dependent protein kinase catalytic subunit, a Ku70, or a Ku80. This invention also provides a method of treating a tumor in a subject, comprising administering to the subject an antisense oligonucleotide that specifically hybridizes to a nucleic acid encoding a DNA dependent protein kinase subunit so as to prevent expression of the DNA dependent protein kinase subunit; wherein the antisense oligonucleotide is in an amount sufficient to increase the sensitivity of the tumor to heat, chemical or radiation-induced DNA damage; and wherein the DNA dependent protein kinase subunit is a DNA dependent protein kinase catalytic subunit, a Ku70, or a Ku80. This invention provides an antisense oligonucleotide that specifically hybridizes to a nucleic acid encoding a DNA dependent protein kinase subunit, wherein the DNA dependent protein kinase subunit is a DNA, dependent protein kinase catalytic subunit, Ku70, or Ku80, so as to prevent expression of the DNA dependent protein kinase subunit.
Uses Of Dna-Pk
US Patent:
7700568, Apr 20, 2010
Filed:
Dec 28, 2000
Appl. No.:
09/750410
Inventors:
Gloria C. Li - New York NY, US
Paul W. J. J. Burgman - Astoria NY, US
Paul W. J. J. Burgman - Astoria NY, US
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
International Classification:
A01N 43/04, C12Q 1/68, C12P 19/34, C12N 15/58, C07H 21/04
US Classification:
514 44, 435 6, 435 911, 435 9131, 435458, 514 1, 536 231, 536 245
Abstract:
This invention provides methods for increasing the susceptibility of cells to DNA-damaging agents, and for treating tumors in a subject, comprising introducing antisense that prevent expression of DNA dependent protein kinase catalytic subunit Ku70 or Ku80, wherein the antisense is in an amount sufficient to increase the sensitivity of the cells and tumors to heat, chemical, or radiation-induced DNA damage.